CPL Biologicals completes structure of vaccine service in Dholka, India CPL Biologicals , a jv of Cadila Pharmaceuticals Ltd. And Novavax, Inc. , announced that it has completed construction of its vaccine service in Dholka today, India and can commence equipment and installation validation this month so the service conforms to global criteria for creation of vaccines for human being use for sale . The new facility utilizes state-of-the-art apparatus for fast and efficient production of up to potentially 60 million doses of novel vaccines every year.